These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7984887)

  • 1. [Proton pump inhibitors in the treatment of reflux esophagitis].
    Bigard MA
    Rev Prat; 1994 Oct; 44(15):1992-6. PubMed ID: 7984887
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitors.
    Grover JK; Vats V
    Trop Gastroenterol; 1999; 20(1):16-28. PubMed ID: 10464444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
    Müller P; Fuchs W; Peifer-Weiss A; Simon B
    Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
    [No Abstract]   [Full Text] [Related]  

  • 4. [Graded therapy in reflux disease. "In severe cases 40 mg., in milder 20 mg."].
    Gillessen A
    MMW Fortschr Med; 2004 Mar; 146(11):54. PubMed ID: 15152771
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rapidity of pain relief, medication requirement and patient satisfaction with reflux treatment in the physician's office].
    Dohmen W; Fuchs W
    MMW Fortschr Med; 2005 Mar; 147(9):39. PubMed ID: 15794353
    [No Abstract]   [Full Text] [Related]  

  • 6. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is lansoprazole (Prevacid) or omeprazole (Prilosec) more effective in treating erosive esophagitis?
    Kim JD
    J Fam Pract; 2002 Apr; 51(4):384. PubMed ID: 11978268
    [No Abstract]   [Full Text] [Related]  

  • 8. Asymptomatic giardiasis--an association with proton pump inhibitors?
    Mukherjee S
    Am J Gastroenterol; 2000 Dec; 95(12):3666-7. PubMed ID: 11151928
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acid inhibitors for asthma patients].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.
    Katz PO
    Rev Gastroenterol Disord; 2006; 6(3):136-45. PubMed ID: 16957654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regeneration of the esophagus epitheliocytes. Evaluation of pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA; Lipatova TE; Chaplygin NV
    Eksp Klin Gastroenterol; 2002; (2):43-6, 102. PubMed ID: 12046386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA; Lipatova TE; Chaplygin NV
    Eksp Klin Gastroenterol; 2002; (4):23-6, 131. PubMed ID: 12503269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC
    Am J Manag Care; 2000 Aug; 6(8):934-5. PubMed ID: 11186505
    [No Abstract]   [Full Text] [Related]  

  • 14. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of gastroesophageal reflux with proton pump inhibitors].
    Vallot T; Carella G
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S97-109. PubMed ID: 10078438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current concepts in therapy of reflux disease].
    Kirchgatterer A; Aschl G; Hinterreiter M; Stadler B; Knoflach P
    Wien Med Wochenschr; 2001; 151(11-12):266-9. PubMed ID: 11515224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
    Cherniakevich SA; Babkova IV; Mikhalev AI
    Klin Med (Mosk); 2002; 80(9):52-4. PubMed ID: 12416227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study.
    Morreale A
    Manag Care Interface; 2001; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.